Advanced search
Publication Cover
Acta Oto-Laryngologica Volume 122, 2002 - Issue 6
Submit an article Journal homepage
15
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Anthrax: What Should the Otolaryngologist Know?

Patrick J. Bradley Department of Otorhinolaryngology - Head and Neck Surgery, Queen's Medical Centre, Nottingham, UK
,
Alfio Ferlito Department of Otolaryngology - Head and Neck Surgery, University of Udine, Udine, Italy
,
Margaret S. Brandwein Department of Pathology and Otolaryngology, Mount Sinai School of Medicine, New York, New York, USA
,
Michael S. Benninger Department of Otolaryngology - Head and Neck Surgery, Henry Ford Hospital, Detroit, Michigan, USA
&
Alessandra Rinaldo Department of Otolaryngology - Head and Neck Surgery, University of Udine, Udine, Italy
Pages 580-585 | Published online: 08 Jul 2009

  • Hanna P. Anthrax pathogenesis and host response. Curr Top Microbiol Immunol 1998; 225: 13-35.
  • Hugh-Jones M. 1996-97 global anthrax report. J Appl Microbiol 1999: 87: 189-91.
  • Inglesby TV, O,Toole T, Henderson DA, et al. Anthrax as a biological weapon, 2002. Updated recommendations for management. JAMA 2002: 287: 223652.
  • Wirtschafter A, Cherukuri S, Benninger MS. Anthrax: ENT manifestations and current concepts. Otolaryngol Head Neck Surg 2002: 126: 8-13.
  • Freedman A, Afonja O, Chang MW, et al. Cutaneous anthrax associated with microangiopathic hemolytic anemia and coagulopathy in a 7-month-old infant. JAMA 2002: 287: 869-74.
  • Barakat LA, Quentzel HL, Jernigan JA, et al. Fatal inhalational anthrax in a 94-year-old Connecticut woman. JAMA 2002: 287: 863-8.
  • Mina B, Dym JP, Kuepper F, et al. Fatal inhalational anthrax with unknown source of exposure in a 61-yearold woman in New York City. J Am Med Assoc 2002: 287: 858-62.
  • Jernigan JA, Stephens DS, Ashford DA, et al. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis 2001: 7; 933-44.
  • Penn CC, Klotz SA. Anthrax pneumonia. Semin Respir Infect 1997: 12: 28-30.
  • Shafazand S, Doyle R, Ruoss S, Weinacker A, Raffin TA. Inhalational anthrax: epidemiology, diagnosis, and management. Chest 1999; 116: 1369-76.
  • Friedlander AM. Anthrax: clinical features, pathogenesis, and potential biological warfare threat. Curr Clin Top Infect Dis 2000; 20: 335-49.
  • Pile JC, Malone JD, Hitzen EM, Friedlander AM. Anthrax as a potential biological warfare agent. Arch Intern Med 1998: 158: 429-34.
  • Watson A, Keir D. Information on which to base assessments of risk from environments contaminated with anthrax spores. Epidemiol Infect 1994: 113: 47990.
  • Baillie L, Read TD. Bacillus anthracis, a bug with attitude! Curr Opin Microbiol 2001; 4: 78-81.
  • Dixon TC, Meselson M, Guillemin J, Hanna PC. Anthrax. N Engl J Med 1999: 341: 815-26.
  • Duesbery NS, Van de Woude GF. Anthrax toxins. Cell MoI Life Sei 1999; 55: 1599-609.
  • Navacharoen N, Sirisanthana T, Navacharoen W, Ruckphaopunt K. Oropharyngeal anthrax. J Laryngol Otol 1985; 99: 1293-5.
  • Doganay M, Almac A, Hanagasi R. Primary throat anthrax. A report of six cases. Scand J Infect Dis 1986: 18: 415-9.
  • Sirisanthana T, Navachareon N, Tharavichitkul P, Sirisanthana V, Brown AE. Outbreak of oral-oropharyngeal anthrax: an unusual manifestation of human infection with Bacillus anthracis. Am J Trop Med Hyg 1984: 33: 144-50.
  • Carr EA, Rew RR. Recovery of Bacillus anthracis from the nose and throat of apparently healthy workers. J Infect Dis 1957: 100: 169-71.
  • Krauss F. Anthrax appearing primarily in the nose. Arch Otolaryngol 1943; 37: 238-41.
  • Walker DH. Anthrax. In: Guerrant RL, Krogstad DJ, Maguire JH, Walker DH, Weller PF, eds. Tropical infectious diseases, principles, pathogens, and practice. Philadelphia, PA: Churchill Livingstone, 1999: 486-91.
  • Inglesby TV, Henderson DA, Bartlett JG, et al. Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA 1999; 281: 1735-45.
  • Swartz MN. Recognition and management of anthrax-an update. N Engl J Med 2001: 345: 1621-6.
  • Bonn D. Anthrax update. Lancet Infect Dis 2002: 2: 64.
  • Franz DR, Jahrling PB, Friedlander AM, et al. Clinical recognition and management of patients exposed to biological warfare agents. JAMA 1997: 278: 399411.
  • Swartz MN. Recognition and management of anthrax. N Engl J Med 2002: 346: 943-5.
  • Ibrahim KH, Brown G. Wright DH, Rotschafer JC. Bacillus anthracis: medical issues of biological warfare. Pharmacotherapy 1999: 19:690-701.
  • Cieslak TJ, Eitzen EM Jr. Clinical and epidemiologic principles of anthrax. Emerg Infect Dis 1999: 5: 552-5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.